Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Blat

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|December 15, 2007
A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilitiesDan Blat, Lev Weiner, Moussa B H Youdim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014
Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cellsDan Blat, Ehud Zigmond, Zoya Alteber, et al.
Immunology and Cell Biology|January 23, 2018
The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiotaZoya Alteber, Adi Sharbi-Yunger, Meirav Pevsner-Fischer, et al.
Bioorganic & Medicinal Chemistry|January 4, 2011
Intramolecular azo-bridge as a cystine disulfide bond surrogate: Somatostatin-14 and brain natriuretic peptide (BNP) analogsGil Fridkin, Theodosia Maina, Berthold A Nock, et al.
Nano Letters|October 12, 2011
Electrically controlled molecular recognition harnessed to activate a cellular responseArbel Artzy-Schnirman, Dan Blat, Yael Talmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2014
Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholdsRavit Oren, Moran Hod-Marco, Maya Haus-Cohen, et al.
Cancer Immunology Research|April 9, 2024
Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor EffectsAssaf Menachem, Zoya Alteber, Gady Cojocaru, et al.
Plos One|October 16, 2018
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) moleculesJane Harper, Katherine J Adams, Giovanna Bossi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|December 15, 2007
A Novel iron-chelating derivative of the neuroprotective peptide NAPVSIPQ shows superior antioxidant and antineurodegenerative capabilitiesDan Blat, Lev Weiner, Moussa B H Youdim, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 2, 2014
Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cellsDan Blat, Ehud Zigmond, Zoya Alteber, et al.
Immunology and Cell Biology|January 23, 2018
The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiotaZoya Alteber, Adi Sharbi-Yunger, Meirav Pevsner-Fischer, et al.
Bioorganic & Medicinal Chemistry|January 4, 2011
Intramolecular azo-bridge as a cystine disulfide bond surrogate: Somatostatin-14 and brain natriuretic peptide (BNP) analogsGil Fridkin, Theodosia Maina, Berthold A Nock, et al.
Nano Letters|October 12, 2011
Electrically controlled molecular recognition harnessed to activate a cellular responseArbel Artzy-Schnirman, Dan Blat, Yael Talmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 2, 2014
Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholdsRavit Oren, Moran Hod-Marco, Maya Haus-Cohen, et al.
Cancer Immunology Research|April 9, 2024
Unleashing Natural IL18 Activity Using an Anti-IL18BP Blocker Induces Potent Immune Stimulation and Antitumor EffectsAssaf Menachem, Zoya Alteber, Gady Cojocaru, et al.
Plos One|October 16, 2018
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) moleculesJane Harper, Katherine J Adams, Giovanna Bossi, et al.
Pageof 1